Macrophage-derived exosome piR-50971 exacerbates sepsis-induced myocardial injury by inhibiting autophagy through the upregulation of N6-Methyladenosine modification of mTOR

Burns & Trauma ›› 2025, Vol. 13 ›› Issue (1) : tkaf045

PDF (2694KB)
Burns & Trauma ›› 2025, Vol. 13 ›› Issue (1) :tkaf045 DOI: 10.1093/burnst/tkaf045
Research Article
research-article
Macrophage-derived exosome piR-50971 exacerbates sepsis-induced myocardial injury by inhibiting autophagy through the upregulation of N6-Methyladenosine modification of mTOR
Author information +
History +
PDF (2694KB)

Abstract

Background: Sepsis-induced myocardial injury (SIMI) is recognized as a severe complication of sepsis which characterized by a high mortality rate. Notably, the pathophysiology of SIMI involves complex mechanisms, including dysregulation of autophagy. Exosomes contribute to crucial biological processes during sepsis, modulating autophagy processes and facilitating communication between cells. PIWI-interacting RNAs (piRNAs) are highly expressed in myocardial tissue and exert cardiovascular regulation properties. Therefore, we investigated the role of macrophage-derived exosome piRNAs, specifically piR-50971, in SIMI and their impact on autophagy through N6-Methyladenosine (m6A) modification of mTOR. Methods: A cecal ligation and puncture model was established to mimic the pathophysiological features of SIMI. Plasma exosomes were isolated and sequenced to characterize the expression of sepsis-related piRNAs. Bioinformatics analysis was employed to predict the potential regulatory mechanisms involving piR-50971. To investigate the direct interaction between piR-50971 and mTOR, a dual-luciferase reporter assay was conducted. Moreover, a methylated RNA immunoprecipitation assay was conducted to verify the involvement of piR-50971 in the m6A methylation modification of mTOR transcripts. Additionally, the m6A methylation level was assessed using dot blotting. Left ventricular ejection fraction and left ventricular fractional shortening of rats were detected by animal echocardiography. Transmission electron microscopy was used to detect autophagy flux in the myocardial tissue of rats in vivo. Cardiac enzymes were detected using a biochemical analyzer. Results: piR-50971 was identified as a key piRNA upregulated in plasma exosomes during SIMI, which was correlated with the inhibition of autophagy. Increased macrophage infiltration was observed in the myocardium of rats with SIMI. Additionally, cardiomyocytes treated with macrophage-derived exosomes exhibited impaired autophagy. RNA binding protein immunoprecipitation assay demonstrated an interaction between Wilms’ tumor 1-associated protein (WTAP) protein and mTOR mRNA. piR-50971 interacted with mTOR, leading to increased m6A modification through the regulation of WTAP and subsequent suppression of autophagy. Notably, this regulation upregulated mTOR translation, thereby inhibiting autophagy and exacerbating myocardial injury under septic conditions. In vivo experiments demonstrated that piR-50971 inhibition ameliorated myocardial injury and improved autophagy in rats with SIMI. Conclusions: Our findings reveal a novel mechanism by which macrophage-derived exosome piR-50971 contributes to SIMI by suppressing autophagy via m6A modification of mTOR. Overall, our results implicate piR-50971 as a potential target for therapeutic intervention in sepsis-related myocardial dysfunction.

Cite this article

Download citation ▾
Jiaqiang Wang, Jie Zhang, Shan Zhong, Xuelian Chen, Hsin-Ying Liu, Chenghao Lu, Hanting Zhu, Yunsheng Chen, Jizhuang Wang, Jiarong Yu, Xiong Zhang, Yan Liu, Min Gao. Macrophage-derived exosome piR-50971 exacerbates sepsis-induced myocardial injury by inhibiting autophagy through the upregulation of N6-Methyladenosine modification of mTOR. Burns & Trauma, 2025, 13 (1) : tkaf045 DOI:10.1093/burnst/tkaf045

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 801-10. https://doi.org/10.1001/jama.2016.0287.

[2]

Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13: 862-74. https://doi.org/10.1038/nri3552.

[3]

Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018; 14: 121-37. https://doi.org/10.1038/nrneph.2017.165.

[4]

Ye Q, Wang X, Xu X, Chen J, Christiani DC, Chen F, et al. Serial platelet count as a dynamic prediction marker of hospital mortality among septic patients. Burns Trauma. 2024; 12: tkae016. https://doi.org/10.1093/burnst/tkae016.

[5]

Lim GB. Cardiac-resident macrophages protect against sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2023; 20: 141. https://doi.org/10.1038/s41569-023-00837-7.

[6]

Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021; 18: 424-34. https://doi.org/10.1038/s41569-020-00492-2.

[7]

Iyer S, Kennedy JN, Jentzer JC, Senussi MH, Seymour CW. Cardiac function before sepsis and clinical outcomes. JAMA. 2024; 331: 1496-9. https://doi.org/10.1001/jama.2024.3917.

[8]

Richard M, Amiens P, Arregle F, Courand PY, Seve P. Myocardial calcification: a rare consequence of streptococcal toxic shock. Lancet. 2023; 401: 1691. https://doi.org/10.1016/S0140-6736(23)00682-7.

[9]

Brechot N, Hajage D, Kimmoun A, Demiselle J, Agerstrand C, Montero S, et al. Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet. 2020; 396: 545-52. https://doi.org/10.1016/S0140-6736(20)30733-9.

[10]

Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023; 20: 7-23. https://doi.org/10.1038/s41569-022-00735-4.

[11]

Wang R, Xu Y, Fang Y, Wang C, Xue Y, Wang F, et al. Pathogenetic mechanisms of septic cardiomyopathy. J Cell Physiol. 2022; 237: 49-58. https://doi.org/10.1002/jcp.30527.

[12]

Song C, Zhang Y, Pei Q, Zheng L, Wang M, Shi Y, et al. HSP70 alleviates sepsis-induced cardiomyopathy by attenuating mitochondrial dysfunction-initiated NLRP3 inflammasome-mediated pyroptosis in cardiomyocytes. Burns Trauma. 2022; 10: tkac043. https://doi.org/10.1093/burnst/tkac043.

[13]

Hsieh CH, Pai PY, Hsueh HW, Yuan SS, Hsieh YC. Complete induction of autophagy is essential for cardioprotection in sepsis. Ann Surg. 2011; 253: 1190-200. https://doi.org/10.1097/SLA.0b013e318214b67e.

[14]

Liu C, Liu Y, Chen H, Yang X, Lu C, Wang L, et al. Myocardial injury: where inflammation and autophagy meet. Burns Trauma. 2023; 11: tkac062. https://doi.org/10.1093/burnst/tkac062.

[15]

Ho J, Yu J, Wong SH, Zhang L, Liu X, Wong WT, et al. Autophagy in sepsis: degradation into exhaustion? Autophagy. 2016; 12: 1073-82. https://doi.org/10.1080/15548627.2016.1179410.

[16]

Sun Y, Yao X, Zhang QJ, Zhu M, Liu ZP, Ci B, et al. Beclin-1-dependent autophagy protects the heart during sepsis. Circulation. 2018; 138: 2247-62. https://doi.org/10.1161/CIRCULATIONAHA.117.032821.

[17]

Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019; 88: 487-514. https://doi.org/10.1146/annurev-biochem-013118-111902.

[18]

Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010; 464: 104-7. https://doi.org/10.1038/nature08780.

[19]

Iwasaki YW, Siomi MC, Siomi H. PIWI-interacting RNA: its biogenesis and functions. Annu Rev Biochem. 2015; 84: 405-33. https://doi.org/10.1146/annurev-biochem-060614-034258.

[20]

Wang X, Ramat A, Simonelig M, Liu MF. Emerging roles and functional mechanisms of PIWI-interacting RNAs. Nat Rev Mol Cell Biol. 2023; 24: 123-41. https://doi.org/10.1038/s41580-022-00528-0.

[21]

Ray R, Pandey P. piRNA analysis framework from small RNA-Seq data by a novel cluster prediction tool-PILFER. Genomics. 2018; 110: 355-65. https://doi.org/10.1016/j.ygeno.2017.12.005.

[22]

Gao J, Chen X, Shan C, Wang Y, Li P, Shao K. Autophagy in cardiovascular diseases: role of noncoding RNAs. Mol Ther Nucleic Acids. 2021; 23: 101-18. https://doi.org/10.1016/j.omtn.2020.10.039.

[23]

Manetti AC, Maiese A, Paolo MD, De Matteis A, La Russa R, Turillazzi E, et al. MicroRNAs and sepsis-induced cardiac dysfunction: a systematic review. Int J Mol Sci. 2020;22. https://doi.org/10.3390/ijms22010321.

[24]

Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019; 20: 608-24. https://doi.org/10.1038/s41580-019-0168-5.

[25]

Huang H, Weng H, Chen J. M(6)a modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020; 37: 270-88. https://doi.org/10.1016/j.ccell.2020.02.004.

[26]

Wang Y, Xu M, Yue P, Zhang D, Tong J, Li Y. Novel insights into the potential mechanisms of N6-Methyladenosine RNA modification on sepsis-induced cardiovascular dysfunction: an update summary on direct and indirect evidences. Front Cell Dev Biol. 2021; 9: 772921. https://doi.org/10.3389/fcell.2021.772921.

[27]

Qian W, Zhou J, Shou S. Exploration of m(6)a methylation regulators as epigenetic targets for immunotherapy in advanced sepsis. BMC Bioinformatics. 2023; 24: 257. https://doi.org/10.1186/s12859-023-05379-w.

[28]

Lai H, Li Y, Zhang H, Hu J, Liao J, Su Y, et al. exoRBase 2.0: an atlas of mRNA, lncRNA and circRNA in extracellular vesicles from human biofluids. Nucleic Acids Res. 2022; 50: D118-28. https://doi.org/10.1093/nar/gkab1085.

[29]

Wu C, Chen Y, Wang Y, Xu C, Cai Y, Zhang R, et al. The m6A methylation enzyme METTL14 regulates myocardial ischemia/reperfusion injury through the Akt/mTOR signaling pathway. Mol Cell Biochem. 2024; 479: 1391-400. https://doi.org/10.1007/s11010-023-04808-x.

[30]

Liu J, Zuo H, Wang Z, Wang W, Qian X, Xie Y, et al. The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling. Cell Prolif. 2023; 56: e13410. https://doi.org/10.1111/cpr.13410.

[31]

Luo X, Cao M, Gao F, He X. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition. Exp Hematol Oncol. 2021; 10: 35. https://doi.org/10.1186/s40164-021-00227-0.

[32]

Zhang Y, Liu X, Wang Y, Lai S, Wang Z, Yang Y, et al. The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol Cancer. 2022; 21: 174. https://doi.org/10.1186/s12943-022-01647-0.

[33]

Chen H, Gao S, Liu W, Wong CC, Wu J, Wu J, et al. RNA N6-Methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 Axis and is a therapeutic target. Gastroenterology. 2021; 160: e16.

[34]

Zhang Q, Zhu Y, Cao X, Tan W, Yu J, Lu Y, et al. The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers. Mol Cancer. 2023; 22: 45. https://doi.org/10.1186/s12943-023-01749-3.

[35]

Gao XQ, Zhang YH, Liu F, Ponnusamy M, Zhao XM, Zhou LY, et al. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N6-methyladenosine methylation of Parp10 mRNA. Nat Cell Biol. 2020; 22: 1319-31. https://doi.org/10.1038/s41556-020-0576-y.

[36]

Han H, Fan G, Song S, Jiang Y, Qian C, Zhang W, et al. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL. Blood. 2021; 137: 1603-14. https://doi.org/10.1182/blood.2019003764.

[37]

Ou B, Liu Y, Gao Z, Xu J, Yan Y, Li Y, et al. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation. Cell Death Dis. 2022; 13: 905. https://doi.org/10.1038/s41419-022-05317-3.

[38]

Zhou J, Xie H, Liu J, Huang R, Xiang Y, Tian D, et al. PIWI-interacting RNAs: critical roles and therapeutic targets in cancer. Cancer Lett. 2023; 562: 216189. https://doi.org/10.1016/j.canlet.2023.216189.

[39]

Ma H, Wang H, Tian F, Zhong Y, Liu Z, Liao A. PIWI-interacting RNA-004800 is regulated by S1P receptor Signaling pathway to keep myeloma cell survival. Front Oncol. 2020; 10: 438. https://doi.org/10.3389/fonc.2020.00438.

[40]

Chen B, Shi B, Zhou Z, Cui Y, Zeng G, Cheng L, et al. Targeting a cardiac abundant and fibroblasts-specific piRNA (CFRPi) to attenuate and reverse cardiac fibrosis in pressure-overloaded heart failure. Transl Res. 2024; 267: 10-24. https://doi.org/10.1016/j.trsl.2024.01.003.

[41]

Kong L, Wu Y, Hu W, Liu L, Xue Y, Liang G. Mechanisms underlying reproductive toxicity induced by nickel nanoparticles identified by comprehensive gene expression analysis in GC-1 spg cells. Environ Pollut. 2021; 275: 116556. https://doi.org/10.1016/j.envpol.2021.116556.

[42]

Zhang S, Liu F, Wu Z, Xie J, Yang Y, Qiu H. Contribution of m6A subtype classification on heterogeneity of sepsis. Ann Transl Med. 2020; 8: 306. https://doi.org/10.21037/atm.2020.03.07.

[43]

Song MM, Li P, Jin XY, Su JD, Sun BW. Effects of endotoxin/lipopolysaccharide on early apoptosis of human neutrophil through PIM3. Zhonghua Shao Shang Za Zhi. 2018; 34: 809-14. https://doi.org/10.3760/cma.j.issn.1009-2587.2018.11.017.

[44]

Fei X, Sheng ZY, Yao YM. Update in immune regulatory dysfunction of dendritic cells in sepsis. Zhonghua Shao Shang Za Zhi. 2020; 36: 150-5. https://doi.org/10.3760/cma.j.issn.1009-2587.2020.02.014.

[45]

Piquereau J, Godin R, Deschenes S, Bessi VL, Mofarrahi M, Hussain SN, et al. Protective role of PARK2/parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction. Autophagy. 2013; 9: 1837-51. https://doi.org/10.4161/auto.26502.

[46]

Cheng W, Zhang J, Li D, Lei X, Wang H, Cui N. CTLA-4 expression on CD4(+) lymphocytes in patients with sepsis-associated immunosuppression and its relationship to mTOR mediated autophagic-lysosomal disorder. Front Immunol. 2024; 15: 1396157. https://doi.org/10.3389/fimmu.2024.1396157.

[47]

Lou J, Wang X, Zhang H, Yu G, Ding J, Zhu X, et al. Inhibition of PLA2G4E/cPLA2 promotes survival of random skin flaps by alleviating lysosomal membrane permeabilization-induced necroptosis. Autophagy. 2022; 18: 1841-63. https://doi.org/10.1080/15548627.2021.2002109.

[48]

Geng Y, Lou J, Wu J, Tao Z, Yang N, Kuang J, et al. NEMO-binding domain/IKKgamma inhibitory peptide alleviates neuronal Pyroptosis in spinal cord injury by inhibiting ASMase-induced lysosome membrane permeabilization. Adv Sci (Weinh). 2024; 11:e2405759. https://doi.org/10.1002/advs.202405759.

[49]

Shi Y, Wu D, Wang Y, Shao Y, Zeng F, Zhou D, et al. Treg and neutrophil extracellular trap interaction contributes to the development of immunosuppression in sepsis. JCI Insight. 2024; 9: 9. https://doi.org/10.1172/jci.insight.180132.

[50]

Jin X, Xia T, Luo S, Zhang Y, Xia Y, Yin H. Exosomal lipid PI4P regulates small extracellular vesicle secretion by modulating intraluminal vesicle formation. J Extracell Vesicles. 2023; 12: e12319. https://doi.org/10.1002/jev2.12319.

[51]

Kumari P, Vasudevan SO, Russo AJ, Wright SS, Fraile-Agreda V, Krajewski D, et al. Host extracellular vesicles confer cytosolic access to systemic LPS licensing non-canonical inflammasome sensing and pyroptosis. Nat Cell Biol. 2023; 25: 1860-72. https://doi.org/10.1038/s41556-023-01269-8.

[52]

Xie Q, Ye Z, Chen L, Zhao C, Ruan Q, Xie W. Expression of microRNA-126 in myocardial tissue of rats in the early stage of severe burn injury and its relation with myocardial damage. Zhonghua Shao Shang Za Zhi. 2015; 31: 367-71.

[53]

Catalano M, O’Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles. 2020; 9: 1703244. https://doi.org/10.1080/20013078.2019.1703244.

[54]

Mokarram P, Niknam M, Sadeghdoust M, Aligolighasemabadi F, Siri M, Dastghaib S, et al. PIWI interacting RNAs perspectives: a new avenues in future cancer investigations. Bioengineered. 2021; 12: 10401-19. https://doi.org/10.1080/21655979.2021.1997078.

[55]

Wang Y, Yao L, Teng Y, Yin H, Wu Q. PIWIL1 drives chemoresistance in multiple myeloma by modulating mitophagy and the myeloma stem cell population. Front Oncol. 2021; 11: 783583. https://doi.org/10.3389/fonc.2021.783583.

[56]

Gong C, Wu J, Li H, Luo C, Ji G, Guan X, et al. METTL3 achieves lipopolysaccharide-induced myocardial injury via m(6)A-dependent stabilization of Myh3 mRNA. Biochim Biophys Acta Mol Cell Res. 2023; 1870: 119503. https://doi.org/10.1016/j.bbamcr.2023.119503.

[57]

Wang X, Ding Y, Li R, Zhang R, Ge X, Gao R, et al. N(6)-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice. Nat Commun. 2023; 14: 1185. https://doi.org/10.1038/s41467-023-36865-7.

[58]

Zhang H, Wu D, Wang Y, Guo K, Spencer CB, Ortoga L, et al. METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury. Clin Transl Med. 2023; 13: e1389. https://doi.org/10.1002/ctm2.1389.

[59]

Zhang X, Jiang X, Deng H, Yu G, Yang N, Al Mamun A, et al. Engineering exosomes from fibroblast growth factor 1 pre-conditioned adipose-derived stem cells promote ischemic skin flaps survival by activating autophagy. Mater Today Bio. 2024; 29: 101314. https://doi.org/10.1016/j.mtbio.2024.101314.

[60]

Zhang K, Zhang X, Cai Z, Zhou J, Cao R, Zhao Y, et al. A novel class of microRNA-recognition elements that function only within open reading frames. Nat Struct Mol Biol. 2018; 25: 1019-27. https://doi.org/10.1038/s41594-018-0136-3.

[61]

Dai P, Wang X, Gou LT, Li ZT, Wen Z, Chen ZG, et al. A translation-activating function of MIWI/piRNA during mouse spermiogenesis. Cell. 2019; 179: 1566-1581.e16. https://doi.org/10.1016/j.cell.2019.11.022.

PDF (2694KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉